Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation by Mancuso, Christy J. et al.
 
Innate immune activation in neonatal tracheal aspirates suggests
endotoxin-driven inflammation
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Nathe, Katheryn E., Christy J. Mancuso, Richard Parad, Linda J.
Van Marter, Camilia R. Martin, Liat Stoler-Barak, Victoria J.
Philbin, Michele F. Phillips, Christine D. Palmer, and Ofer
Levy. 2012. Innate immune activation in neonatal tracheal
aspirates suggests endotoxin-driven inflammation. Pediatric
Research 72(2): 203-211.
Published Version doi:10.1038/pr.2012.61
Accessed February 19, 2015 10:47:32 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10436299
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAVolume 72  |  Number 2  |  August 2012        Pediatric ReseARch  203 copyright © 2012 International Pediatric Research Foundation, Inc.
Articles Clinical Investigation
nature publishing group
Background:  Tracheal  aspirates  (TAs)  from  critically  ill 
neonates  accumulate  bacterial  endotoxin  and  demonstrate 
mobilization of endotoxin-binding proteins, but the potential 
bioactivity of endotoxin in TAs is unknown. We characterized 
innate immune activation in TAs of mechanically ventilated 
neonates.
Methods:  Innate  immune  activation  in  TAs  of  mechani-
cally ventilated neonates was characterized using a targeted 
84-gene quantitative real-time (qRT) PcR array. Protein expres-
sion of cytokines was confirmed by multiplex assay. expression 
and localization of the endotoxin-inducible antimicrobial pro-
tein calgranulin c (s100A12) was assessed by flow cytometry. 
endotoxin levels were measured in TA supernatants using the 
Limulus amoebocyte lysate assay.
results: Analyses by qRT-PcR demonstrated expression of 
pattern recognition receptors, Toll-like receptor-nuclear factor 
κB and inflammasome pathways, cytokines/chemokines and 
their receptors, and anti-infective proteins in TA cells. endotoxin 
positivity  increased  with  postnatal  age.  As  compared  with 
endotoxin-negative TAs, endotoxin-positive TAs demonstrated 
significantly  greater  tumor  necrosis  factor  (TNF),  interleukin 
(IL)-6, IL-10, and serpin peptidase inhibitor, clade e, member 1 
(seRPINe1) mRNA, and IL-10, TNF, and IL-1β protein. expression 
of s100A12 protein was localized to TA neutrophils.
conclusion: correlation of endotoxin with TA inflamma-
tory responses suggests endotoxin bioactivity and the pos-
sibility that endotoxin antagonists could mitigate pulmonary 
inflammation and its sequelae in this vulnerable population.
P
ulmonary disease is a major cause of morbidity in pre-
mature infants (1). Several lines of evidence suggest that 
innate immune activation may play important roles in the 
development of respiratory diseases early in life (2). Preterm, 
mechanically ventilated neonates are predisposed to bacte-
rial tracheal colonization, which is associated with cytokine 
responses that may contribute to pulmonary inflammation (3). 
Indeed, microbial colonization and production of cytokines 
and chemokines such as interleukin (IL)-1β and CXCL8, par-
ticularly early in the course of intubation, has been associated   
with subsequent respiratory disease (4,5).
Innate  immune  activation  in  the  newborn  is  incompletely 
characterized  (6),  especially  with  respect  to  the  respiratory 
tract (7). Pathogen-associated molecular patterns are detected 
by pattern recognition receptors, including Toll-like receptors 
(TLRs) and the intracellular inflammasome complex, pathways 
that induce acute inflammatory responses (8,9). TLRs signal via 
adaptor molecules such as MyD88 (10), and downstream serine-
threonine kinases to induce cytokines via activation of transcrip-
tion factors including nuclear factor κB (NFκB) and interferon 
regulatory transcription factor family members (11,12).
Bacterial endotoxin found in all Gram-negative bacteria is 
one of the most potent known activators of the TLR pathway; 
it is active at picogram concentrations. Detection of bacterial 
endotoxin by the endotoxin receptor complex composed of 
CD14/TLR4/MD2 induces production of cytokines, including 
tumor necrosis factor (TNF) and IL-6 (11,13,14), IL-1 family 
members via the inflammasome (9), antiinflammatory cytok-
ines such as IL-10 (15), and chemokines that attract infiltrat-
ing polymorphonuclear leukocytes (PMNs) and monocytes to 
sites of infection (16,17).
Cells respond to secreted cytokines and chemokines via cog-
nate  receptors  (18),  leading  to  further  production  of  inflam-
matory  response  genes,  including  complement  proteins  and 
anti-infective proteins and peptides (19). These are secreted into 
the respiratory tract in response to infection via direct synthe-
sis by tracheobronchial epithelial cells (20) and/or by cytokine/
chemokine-based  recruitment  and  activation  of  PMNs  (21). 
Regulatory molecules such as heme-oxygenase-1 (HMOX1) and 
serpin peptidase inhibitors can further modulate host responses 
(22,23). Overall, little is known regarding the relative expression of 
these pathways in the airways of intubated preterm newborns.
We have previously reported the presence of Gram-negative 
bacterial  endotoxin  in  tracheal  aspirates  (TAs),  along  with 
mobilization of endotoxin-directed proteins such as sCD14, 
lipopolysaccharide  binding  protein  and  bactericidal/perme-
ability increasing protein (24). This study raised the possibility 
that endotoxin may contribute to respiratory inflammation in 
this setting. However, neither the scope of innate immune acti-
vation in TAs nor the potential correlation of endotoxin with 
inflammatory responses has been characterized.
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To  characterize  innate  immune  activation  in  neona-
tal TAs in relation to endotoxin, we employed a targeted 
  transcriptional profiling approach using quantitative real-
time (qRT)-PCR using TA samples of limited volume and cell 
number. Our objectives were to (i) determine the   feasibility 
of the qRT-PCR approach to TA transcriptional profiling, 
(ii)  validate  this  approach  by  characterizing  expression 
of select proteins, and (iii) assess potential correlations of 
innate immune expression with the presence of endotoxin.
Herein, we demonstrate the feasibility and validity of a qRT-
PCR approach to characterize activation of innate immune path-
ways in neonatal TAs, revealing broad transcriptional activation 
CD1D TNFRSF1A
IFNGR2
IFNGR1
CCR3
CXCR4
IL1RAPL2
IL12RB2
IL1R1
IL1RAP
IL1R2
IL1RN
DMBT1
SFTPD
COLEC12
NLRC4
TREM1
TLR10
TLR3
TLR9
TLR8
TLR1
TLR6
TLR2
TLR4
MD2
CD14
IRF1 CRP
C8A
C5
LBP
PGLYRP2
PGLYRP3
PGLYRP1
NOS2A
DEFB4
LTF
CAMP
BPI
NCF4
CYBB
S100A12
LYZ
LALBA
SERPINE1
FN1
PROC
PTAFR
ADORA2A
HMOX1
SERPINA1
MAPK8
MAPK14
TRAF6
TOLLIP
IRAK1
IRAK2
MYD88
CASP1
CASP4
IKBKB
NFKB2
CHUK
NFKB1
NFKBIA
IL6
TNF
IFNA1
IFNB1
IL10
MIF
TGFB1
IL1F10
IL1F7
IL1F5
IL1F9
IL1A
IL1B
CXCL7
CCL2
CXCL8
11 0 10
2 10
3
Relative mRNA abundance
10
4 10
5 11 0 10
2 10
3
Relative mRNA abundance
10
4 10
5
11 0 10
2 10
3
Relative mRNA abundance
10
4
**
**
10
5
11 0 10
2 10
3
Relative mRNA abundance
10
4 10
5 10
6 11 0 10
2 10
3
Relative mRNA abundance
10
4 10
5
11 0 10
2 10
3
Relative mRNA abundance
10
4 10
5
ad
be
cf
Figure 1.  Innate immune transcriptome of TA pellets. TA pellet mRNA (n = 25, except for CXCL8, for which n = 14) was analyzed by quantitative real-time 
PCR. mRNA levels of 82 genes are shown as mean ± SEM mRNA abundance and grouped by function as follows: (a) pattern recognition receptors, (b) 
intracellular signaling, (c) cytokine/chemokines, (d) cytokine/chemokine receptors, (e) anti-infective, and (f) other. All mRNA transcripts except for LBP were 
consistently detected in all subjects. Statistical analyses by one-way ANOVA, Bonferroni posttest, **P < 0.01, †P < 0.001. Colored stars and daggers signify 
statistically significant differences from the correspondingly colored bar within each graph. LBP, lipopolysaccharide binding protein; TA, tracheal aspirate.
table 1.  Subject characteristics
Subject characteristic
Subjects (n) 53
TA samples collected, total (n) 69
Male %   62%
Gestational age (wk) 27.8 ± 4.2
Gestational age, range (wk) 23–39
Postnatal age, all samples (d)   16.5 ± 16.2
Postnatal age, range, all samples (d) 0–71
Birth weight (g) 1,137 ± 842
Endotoxin-positive %   40%
Bronchopulmonary dysplasia %   55%
Values are represented as mean ± sD, unless otherwise specified.Volume 72  |  Number 2  |  August 2012        Pediatric ReseARch  205 copyright © 2012 International Pediatric Research Foundation, Inc.
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of pattern recognition receptors, signaling molecules, anti-in-
fective proteins, and cytokines. Detected gene expression varied 
by as much as 5 log orders of magnitude. Expression of several 
transcripts was confirmed at the protein level, including multi-
ple cytokines, as well as mobilization of the endotoxin-inducible 
anti-infective protein Calgranulin C (S100A12) localized to TA 
PMNs. Moreover, our studies have revealed that the presence 
of endotoxin in TA supernatants correlates with expression of 
inflammatory cytokines such as TNF and IL-1β, suggesting that 
bioactive endotoxin could contribute to respiratory inflamma-
tion and its sequelae.
RESuLTS
Study Population
Demographics and relevant clinical characteristics of the study 
subjects appear in Table 1. Samples from infants (n = 53) with 
gestational age (GA) range of 23–39 wk are represented, with a 
postnatal age range of 0–71 d.
mRNA Transcript Yield and Abundance
TA pellets, containing 1.97 × 105–1.32 × 107 total viable cells, all 
yielded sufficient quantity (56–1,280 ng) and quality mRNA for 
downstream qRT-PCR, allowing measurement of relative mRNA 
abundance of 86 genes in the innate immune pathway. RNA yield 
(µg/ml) positively correlated with cellularity of the TA pellets. All 
mRNA transcripts except for lipopolysaccharide binding protein, 
which is predominantly an acute-phase liver product, were con-
sistently detected in all subjects tested (25/25). Figure 1 shows 
mRNA levels as mean ± SEM mRNA relative abundance grouped 
by function. CD14, a component of the endotoxin receptor, and 
TREM-1, an endotoxin-inducible receptor that amplifies lipopoly-
saccharide  induced  inflammation  (25),  demonstrated  greater 
expression  than  multiple  other  pattern  recognition  receptors 
(Figure 1a). NFKBIA, a component of the NFκB signaling path-
way, was most abundantly expressed within the intracellular sig-
naling transcripts (Figure 1b). The IL-1 receptor antagonist gene 
(IL-1RN) had the highest expression of the cytokine/chemokine 
receptors (Figure 1c), with CXCL8, a neutrophil chemoattrac-
tant, being expressed at higher levels than most other cytokines/
chemokines (Figure 1d). Among the anti-infective proteins and 
peptides, lysozyme, cytochrome b245 β-chain, and S100A12 dem-
onstrated the greatest expression (Figure 1e). In addition, serpin 
peptidase inhibitor clade A member 1 (SERPINA1) was most 
abundantly expressed within the “other” grouping (Figure 1f).
Assessing S100A12 as a Novel TA Transcript
As S100A12 had not been previously reported in human neo-
natal TAs, we characterized its expression at the protein level 
by enzyme-linked immunosorbent assay (ELISA). Levels of 
S100A12 positively correlated with TA cell counts as assessed 
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Figure 2.  S100A12 protein expression localizes to TA PMNs. Representative dot plot of TA cells stained with (a) fluorescein isothiocyanate (FITC) and 
R-phycoerythrin (PE) isotype control antibodies and (b) antibodies for cell-surface antigens FITC-CD66b (PMN) and intracellular PE-S100A12 by flow cytome-
try. Representative confocal fluorescent microscopy (100×) of TA cells stained with (c) isotype control antibodies, or (d) antibodies against CD66b (green) and 
S100A12 (red), both with DRAQ5 nuclear stain (blue). (d) A characteristic CD66b+/S100A12+ PMN. PMN, polymorphonuclear leukocyte; TA, tracheal aspirate.206  Pediatric ReseARch       Volume 72  |  Number 2  |  August 2012 copyright © 2012 International Pediatric Research Foundation, Inc.
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by hemocytometry (n = 19; Spearman r = 0.59, P < 0.01). Flow 
cytometry of TA cells for surface CD66b (PMNs) and intrac-
ellular S100A12 demonstrated that CD66b+/S100A12+ PMNs 
represent >50% of the total TA cell population (Figure 2a,b). 
This localization was confirmed by confocal microscopy dem-
onstrating TA cells stained for CD66b (green), S100A12 (red), 
and nuclei (blue; Figure 2c,d).
Characterization of TA Cytokine Protein Concentrations
To further validate our mRNA array results, IL-10, TNF, IL-1β, 
IL-6, CXCL8, and CCL2 protein concentrations were measured 
by multiplex assay. Cytokine/chemokine transcript levels cor-
related with respective protein levels (Figure 3a), suggesting 
that the qRT-PCR approach may be of value in predicting the 
presence of TA inflammatory markers. All six cytokines were 
detectable, with IL-10 produced at the lowest levels (~10 pg/
ml), and CCL2 produced at the highest level (~10,000 pg/ml; 
Figure 3b). Cytokine concentrations did not significantly vary 
by GA, birth weight, sex, subsequent bronchopulmonary dys-
plasia diagnosis, or mean fraction of inspired oxygen (FiO2) 
exposure (data not shown).
Endotoxin-Positive  TAs  Demonstrate  Increased  mRNA 
Expression
As the observed pattern of TA gene transcription and cytokine 
production suggested a possible response to endotoxin (26), 
we next measured endotoxin in TA supernatants by Limulus 
amoebocyte lysate assay (<0.2 endotoxin units (EU)/ml, n = 
32; 0.2–1 EU/ml, n = 7; >1–100 EU/ml, n = 5; >100 EU/ml, n = 
9). Upon analysis of TAs for which bacterial culture was avail-
able, recovery of Gram-negative bacteria significantly corre-
lated with higher endotoxin levels (data not shown). Of the 25 
TA pellets assayed by qRT-PCR, 24 also had TA supernatants 
available for endotoxin testing via Limulus amoebocyte lysate 
assay. As compared with endotoxin-negative samples, endo-
toxin-positive TAs demonstrated significantly greater mRNA 
expression of IL-6, IL-10, TNF, and serpin peptidase inhibi-
tor, clade E, member 1 (SERPINE1) (Figure 4a,b), suggesting 
endotoxin-induced activation of gene transcription.
TA  Supernatant  Cytokines  Correlate  With  Postnatal  Age  and 
Endotoxin Positivity
We next assessed whether protein biomarkers correlated with 
the presence of endotoxin in TAs. Consistent with a lack of 
upregulation of the S100A12 mRNA transcript in endotoxin-
positive TA pellets (Figure 4a), concentrations of S100A12 
protein  were  not  significantly  higher  in  endotoxin-positive 
than in endotoxin-negative TA supernatants (data not shown). 
However, TA supernatants from intubated neonates at post-
natal day of life (DOL) ≥4 d (mean DOL = 15.7 d) expressed 
higher levels of TNF, IL-1β, and CXCL8 than those at DOL<4 
d (mean DOL = 1.2 d; Figure 5a). Indeed, TNF, IL-1β, and 
CXCL8 increased significantly from DOL 0–3 to DOL 4–9 
(Figure  5b).  Postnatal  DOL  also  correlated  with  levels  of 
endotoxin (Figure 5c), and endotoxin-positive TA superna-
tants contained significantly greater concentrations of IL-10, 
TNF, and IL-1β protein than endotoxin-negative TA superna-
tants (Figure 5d), suggesting endotoxin-driven transcription 
of these cytokines. Accordingly, IL-10 levels increased signifi-
cantly in endotoxin-positive TAs from DOL 0–3 to DOL 4–9, 
then decreased over time (Figure 5e).
DISCuSSION
We have characterized for the first time an innate immune 
transcriptome in the TAs of critically ill, mechanically venti-
lated human newborns. Although transcription of nearly all of 
the genes selected (84/85) was detectable, expression of innate 
immunity genes varied substantially across five orders of mag-
nitude. Verification of expression at the protein level (cytokines/
chemokines, S100A12) indicated that mRNA expression was 
predictive of protein expression, and generally proportional in 
magnitude, indicating the robustness of this approach.
The most abundantly expressed anti-infective proteins/pep-
tides in TAs were lysozyme, S100A12, and cytochrome b245 
β-chain, a phagocyte oxidase component important for oxygen 
radical production. Expression of the PMN granule-associated 
lysozyme and bactericidal/permeability increasing protein in 
neonatal  TAs  have  been  previously  reported  (24).  Of  note, 
we are the first to demonstrate PMN-associated expression of 
S100A12 in neonatal TAs. In adult humans, S100A12 is pre-
dominantly expressed in PMNs (27) and in monocytes (28), 
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and its expression can be enhanced in some settings by the 
introduction of endotoxin in vitro or into the bloodstream in 
vivo (29,30). In contrast, in our study, S100A12 protein corre-
lated with TA cell count, but neither S100A12 mRNA nor pro-
tein levels were higher in endotoxin-positive as compared with 
endotoxin-negative TA samples. We speculate that the mecha-
nisms of S100A12 mobilization from neutrophils in the intu-
bated respiratory tract of the neonate are distinct from those in 
adult studies of acute/single endotoxin exposure in vitro or in 
the peripheral blood compartment in vivo.
Upon mobilization to the respiratory tract, S100A12 may 
play  important  roles  in  host  defense  and  inflammation. 
S100A12 is microbicidal through its C-terminal peptide, cal-
citermin, which kills Gram-negative bacteria and Candida 
albicans (31). S100A12 is also released from activated or 
damaged cells under stress (32) and can bind the receptor 
for advanced glycation end-products on pulmonary type I 
alveolar cells and macrophages, triggering NFκB signaling 
and expression of pro-inflammatory cytokines and adhesion 
molecules (33). Accordingly, S100A12 is elevated in bron-
choalveolar lavage fluid of adults with acute respiratory dis-
tress syndrome (29,34) or chronic lung disease (34). Thus, 
S100A12 could help ward off infection and potentially con-
tribute to inflammation, and may also serve as a biomarker 
in this setting.
With  respect  to  cytokines  and  chemokines,  we  observed 
abundant  mRNA  expression  of  CXCL8,  CCL2,  and  IL-1β 
(>103 relative mRNA abundance). These were confirmed at 
the protein level, along with IL-6, IL-10, and TNF, suggesting 
an  intensely  inflammatory  environment.  Expression  of  cas-
pase-1 mRNA coupled with robust IL-1β production indicates 
inflammasome activation in TAs. IL-1β can be present early 
after birth in the setting of chorioamnionitis (35) and may 
contribute to high CXCL8 concentrations via its action on air-
way epithelial cells (5). Abundant expression of CXCL8, a neu-
trophil chemoattractant, and CCL2, important to monocyte, 
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macrophage, and T-cell infiltration, is consistent with other 
studies (4,36).
Several lines of evidence suggest that endotoxin is bioac-
tive in TAs and could contribute to respiratory inflammation 
in our study cohort: (i) endotoxin is detected by the Limulus 
amoebocyte lysate assay and correlates with positive culture 
for  Gram-negative  microorganisms;  (ii)  mRNA  transcripts 
encoding MD2, CD14, and TLR4 (components of the endo-
toxin receptor), as well as downstream MyD88 and NFκB, were 
abundantly expressed, indicating the presence of key endo-
toxin-detecting machinery; (iii) endotoxin-inducible antimi-
crobial proteins and peptides such as S100A12 were robustly 
expressed; (iv) multiple endotoxin-inducible cytokines were 
present; (v) endotoxin-positive TAs had higher transcriptional 
activation of several inflammatory cytokines, including TNF; 
and  (vi)  endotoxin-positive  TAs  demonstrated  higher  pro-
tein concentrations of TNF and IL-1β. Greater postnatal age 
was positively correlated with both endotoxin positivity and 
increased cytokine levels, suggesting a possible role for length 
of intubation (37) and an increased risk of endotoxin-driven 
inflammation. Alternatively, as the group with lower postna-
tal age was also more premature (mean GA 26.3 vs. 32.5 wk), 
increased cytokine concentrations with advancing postnatal 
age in our study population could also reflect the ontogeny/
maturation of the inflammatory response in this age group. 
Thus,  although  cause  and  effect  with  regard  to  length  of 
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intubation (postnatal age in this patient group), prematurity 
(GA), and endotoxin positivity cannot be clearly determined, 
it is nonetheless evident that all these factors can contribute 
to cytokine elevation. Overall, these observations support the 
hypothesis that prolonged mechanical ventilation contributes 
to endotoxin exposure and inflammatory sequelae (1,3).
In sum, we have developed a novel qRT-PCR transcriptional 
approach to characterize broad innate immune activation in 
neonatal TAs, defined relative magnitude of expression within 
classes of innate immune components, identified S100A12 as 
a novel TA biomarker of PMN-driven inflammation, and pro-
vided evidence that bioactive endotoxin in TAs may contribute 
to inflammation, including activation of the NFκB signaling 
cascade that has been linked to bronchopulmonary dysplasia 
(38). In light of the likely contribution of bioactive endotoxin 
to innate immune activation, inflammation, and respiratory 
disease in this setting, endotoxin antagonists (26)—several of 
which are under biopharmaceutical development (39), includ-
ing human clinical trials, and can be administered via the respi-
ratory route (40–42)—may be beneficial to reduce pulmonary 
inflammation in critically ill preterm newborns.
METHODS
Collection and Processing of Neonatal TAs
TAs were collected from mechanically ventilated newborn infants 
(regardless of GA or birth weight) who were intubated for respiratory 
failure at the Brigham and Women’s Hospital (BWH) and the Beth 
Israel Deaconess Medical Center (BIDMC) newborn intensive care 
units (NICUs) as previously described (24), and in accordance with 
BWH and BIDMC IRB–approved protocols. Briefly, TA samples were 
collected from mechanically ventilated newborns BWH and BIDMC 
NICUs. Informed consent was not required as TAs are discarded spec-
imens. TAs were collected after endotracheal instillation of 0.5 ml/kg 
sterile, pyrogen-free saline using sterile suction catheters and placed 
on ice for processing within 4 h. Because of TA volume constraints, 
subsets of samples were analyzed for different markers, with number 
(n) provided in each figure legend. Where available, mean levels of 
FiO2 exposure over total intubation period and TA bacterial culture 
results were obtained and compiled (bacterial cultures ±7 d of collec-
tion of study samples, data not shown).
Purification of TA Pellet RNA
All  pipettes/surfaces  were  cleaned  with  RNase  Zap  (Applied 
Biosystems/Ambion, Austin, TX) to prevent degradation of RNA. TAs 
were transferred to a 1.5-ml polypropylene collection tube and centri-
fuged (700g, for 5 min at room temperature). TA supernatant   aliquots 
were  stored  at  −80 °C.  Cells  were  counted  and  viability  assessed 
(≥85%) by trypan blue exclusion. TA cell pellet RNA was preserved 
by adding 375 µl RNA Cell Protect Reagent (QIAGEN, Valencia, CA). 
TA cell pellet RNA was processed immediately or stored at −80°C. 
RNA was isolated by RNA Protect Cell Mini and RNeasy MinElute 
Cleanup  Kits  (QIAGEN)  per  the  manufacturer’s  instructions.  TA 
mRNA yield positively correlated with TA cellularity as measured by 
hemocytometry (data not shown). RNA concentration was measured 
using a spectrophotometer (absorbance 260/280) or Nanodrop 1000 
spectrophotometer (Thermo Fisher Scientific, Waltham, MA). RNA 
purity was assessed by Nanodrop with A260/280 ratios ranging from 
1.8–2.0 and A260/230 ratios from 2.0–2.2 deemed pure according to 
the manufacturer’s guidelines (http://www.nanodrop.com).
Quantitative Real-Time PCR
Total  mRNA  (100 ng)  was  reverse-transcribed  to  cDNA  using 
the  RT2  First  Strand  Kit  (QIAGEN)  according  to  the  manufac-
turer’s instructions. The equivalent of ~1 ng RNA/well was assayed 
using the RT2 Profiler PCR Array System (QIAGEN) according to 
the  manufacturer’s  instructions.  A  modified  Human  Innate  and 
Adaptive  Immune  Response  RT2  Profiler  PCR  array  was  created 
(CAPH09693-PAHS-052; QIAGEN) containing primers for 86 genes 
of  interest  (including  those  for  bactericidal/permeability  increas-
ing protein and CXCL8) and 10 controls (5 housekeeping genes, 
including those for β-2-microglobulin, hypoxanthine phosphoribo-
syl transferase 1, ribosomal protein L13a, GAPDH, and ACTB, as 
well as human genomic DNA contamination–, reverse transcrip-
tion–, and positive PCR–controls). mRNA levels were normalized 
to  housekeeping  genes  and  quantified  using  the  ΔΔ  comparative 
threshold (Ct) method (43), using an analysis tool from QIAGEN 
(http://www.sabiosciences.com/pcr/arrayanalysis.php). To compare 
mRNA abundance, transcripts were expressed as a ratio of the 2−ΔCt 
value to the 2−ΔCt of the least abundant transcript (lipopolysaccharide 
binding protein, average Ct = 38.976). Statistical analyses compar-
ing mRNA levels of different transcripts were applied when mean 
transcript levels differed by >5.5 cycles (i.e., >44-fold difference), 
as  advised  by  the  associate  director  of  Bioinformatics,  Biological 
Content Development, R&D Americas, QIAGEN.
Milliplex Cytokine Assays
TA  protein  levels  of  IL-1β,  IL-6,  CXCL8,  IL-10,  CCL2,  and  TNF 
were  measured  using  a  customized  Milliplex  Human  Cytokine 
Immunoassay Kit (Millipore, Chicago, IL). using a Milliplex Analyzer 
3.1 Luminex 200 machine (Millipore) and analyzed on corresponding 
software according to the manufacturer’s instructions.
Endotoxin Measurement
Endotoxin was measured by Limulus amoebocyte lysate (Charles River, 
Boston, MA) assay according to the manufacturer’s instructions.
Total Protein Measurement
Total protein was measured using the Bradford protein assay (Bio-
Rad Laboratories, Hercules, CA) with human serum albumin as stan-
dard (Talecris Biotherapeutics, Research Triangle Park, NC).
Measurement of S100A12
S100A12 in TA supernatants was measured by enzyme-linked immu-
nosorbent assay according to the manufacturer’s instructions (CycLex, 
Nagano, Japan).
Flow Cytometry
After TA cell collection, Fc binding sites were blocked using 10% nor-
mal human serum (60 min, room temperature). PMNs were stained 
(20 min,  room  temperature)  with  FITC-conjugated  anti-CD66b 
mAb (mouse IgM, clone G10F5; BD Pharmingen, San Diego, CA) 
at 10 µl/5 × 105 cells, or with FITC-conjugated isotype control mAb 
(mouse IgM, clone G155-228; BD Pharmingen). After washing (Stain 
Buffer; BD Pharmingen) and permeabilization (1× fluorescence acti-
vated cell sorter lysing solution or 1× permeabilization/wash buffer 
containing saponin; BD Pharmingen, 20 min, room temperature), 
S100A12 was detected with mouse IgG1κ anti-S100A12 mAb (clone 
19F5; Santa Cruz Biotechnology, CA; 1µl/5 × 105 cells) or mouse 
IgG1(κ) isotype control mAb (clone MOPC-21; BD Pharmingen), 
followed by incubation (30 min, room temperature) with a second-
ary phycoerythrin-conjugated monoclonal rat anti-mouse IgG1(κ) 
Ab (clone A85-I; BD Pharmingen; 5 µl/5 × 105 cells). Cells were fixed 
(1% formalin and stain buffer, 4 °C) before analysis by flow cytom-
etry (Cytomation MoFlo flow cytometer, DAKO, Carpinteria, CA) 
and analyzed with FloJo Flow Cytometry Analysis Software (Tree 
Star, Ashland, OR).
Fluorescent/Confocal Microscopy
Formalin-fixed  TA  cells  were  stained  with  DRAQ5  (Alexis 
Biochemicals, Farmingdale, NY) nuclear stain 10 min before imag-
ing on a Nikon TE-2000 inverted microscope fitted with a video-rate 
confocal system (Yokogawa, Sugar Land, TX) paired with a Kr/Ar 
laser (Melles Griot, Albuquerque, NM), fluorescence filters, and an 
Orca camera (Hamamatsu, Bridgewater, NJ) for image digitization. 
Slidebook Software (Intelligent Imaging Innovations, Denver, CO) 
was used for image capture and 3-dimensional rendering. Confocal 
images  were  collected  either  as  single  2-dimensional  planes  or 210  Pediatric ReseARch       Volume 72  |  Number 2  |  August 2012 copyright © 2012 International Pediatric Research Foundation, Inc.
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3-dimensional stacks using a 100× oil immersion objective with an 
aperture of 1.4 and a focal step size of 0.3 µ.
Statistics
Statistical analyses of mRNA expression employed SA Biosciences 
software (QIAGEN) using a Student’s t test of the replicate 2−ΔCt val-
ues for each gene in the endotoxin-negative and endotoxin-positive 
sample sets (Figure 4a). Graphpad Prism 5.0a Software (GraphPad 
Software, La Jolla, CA) was used to perform statistical analysis for TA 
supernatant biomarkers and relative mRNA abundance. Data groups 
with unequal variances were analyzed by Mann–Whitney unpaired 
t test. For multiple comparisons, one-way ANOVA repeated-  measures 
test with Bonferroni’s multiple-comparison posttest correction was 
used. Correlations were drawn using the Spearman method. P values 
<0.05 were considered significant.
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